Sézary syndrome: A study of 176 patients at Mayo Clinic
- 1 December 2012
- journal article
- Published by Elsevier BV in Journal of the American Academy of Dermatology
- Vol. 67 (6), 1189-1199
- https://doi.org/10.1016/j.jaad.2012.04.043
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Sézary syndrome: Immunopathogenesis, literature review of therapeutic options, and recommendations for therapy by the United States Cutaneous Lymphoma Consortium (USCLC)Journal of the American Academy of Dermatology, 2010
- Survival Outcomes and Prognostic Factors in Mycosis Fungoides/Sezary Syndrome: Validation of the Revised International Society for Cutaneous Lymphomas/European Organisation for Research and Treatment of Cancer Staging ProposalJournal of Clinical Oncology, 2010
- Cutaneous T-cell LymphomaHematology/Oncology Clinics of North America, 2008
- Long-term outcomes of patients with advanced-stage cutaneous T-cell lymphoma and large cell transformationPublished by American Society of Hematology ,2008
- Mycosis fungoides and Sézary syndromeThe Lancet, 2008
- Revisions to the staging and classification of mycosis fungoides and Sézary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC)Blood, 2007
- Mycosis fungoides and sezary syndrome: an update.Current Oncology Reports, 2006
- WHO-EORTC classification for cutaneous lymphomasBlood, 2005
- Update on erythrodermic cutaneous T-cell lymphoma: Report of the international society for cutaneous lymphomasJournal of the American Academy of Dermatology, 2002
- Prognostic significance of tumor burden in the blood of patients with erythrodermic primary cutaneous T-cell lymphomaBlood, 2001